1 / 17

Duramorph –A Cost Analysis

Duramorph –A Cost Analysis. Scott Frankfather, M.D. PGY IV Robert Casanova, M.D. Texas Tech Physicians Department of Obstetrics and Gynecology March 6, 2009. Duramorph—A Cost Analysis .

jayme
Download Presentation

Duramorph –A Cost Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Duramorph –A Cost Analysis Scott Frankfather, M.D. PGY IV Robert Casanova, M.D. Texas Tech Physicians Department of Obstetrics and Gynecology March 6, 2009

  2. Duramorph—A Cost Analysis • Objective: To evaluate the cost effectiveness of intrathecal morphine during spinal anesthesia for cesarean section.

  3. Duramorph—A Cost Analysis • Background: Cesarean section is the most commonly performed surgery in the United States. 26% of all deliveries in 2002. • Anesthesia includes • Epidural • Spinal • General • Local

  4. Duramorph—A Cost Analysis • Background: • The most common types of anesthesia: • epidural or spinal anesthesia. • The addition of morphine to the intrathecal (spinal) anesthesia is becoming a more common practice • pain relief for up to twenty-four hours • Negates need for patient controlled analgesia (PCA) • Patients require additional medications • Oral narcotics • Intravenous or intramuscular narcotics • Antihistamines • Antiemetics

  5. Duramorph—A Cost Analysis • Background: • A review of literature in PubMed found no study evaluating the cost-effectiveness of intrathecal morphine.

  6. Duramorph—A Cost Analysis • Study Design: • Retrospective chart review comparing medication costs of patients receiving intrathecal morphine anesthesia and matched controls of patients receiving spinal anesthesia with PCA between January 1, 2008 and December 31, 2008 at University Medical Center.

  7. Duramorph—A Cost Analysis • Hypothesis: Intrathecal morphine provides adequate pain relief but is not cost effective when considering all additional medications required by the patient.

  8. Duramorph—A Cost Analysis • Materials and Methods: • The patients were identified using the Premier software with the assistance of the office of Performance Improvement at University Medical Center in Lubbock, Texas. • The costs of all anesthesia related medications following a cesarean section were analyzed.

  9. Duramorph—A Cost Analysis • Gravidity • Parity • Weight • Type of anesthesia • Skin incision • Cost of all pain medication • Cost of medication resulting from administration of anesthesia. • Materials and Methods: • After identifying patients of interest and obtaining the total cost of medications of interest, all patient identifiers were removed from the data. • Data collected included:

  10. Duramorph—A Cost Analysis • Materials and Methods: • Population: 617 patients who underwent a cesarean section between January 1, 2008 and December 31, 2008. • Subdivided into groups according to type of anesthesia • Duramorph Group: 54 Patients • PCA Group: 104 Patients were selected randomly from 517 who received spinal with PCA

  11. Duramorph—A Cost Analysis • Materials and Methods: • Exclusion criteria: • Hospital stays longer than 7 days • n=3 from Duramorph group • n=32 from PCA group • Incomplete medical records (n=2) • Duplicated anesthesia charges (n=18) • No anesthesia charges (n=28)

  12. Results

  13. Results

  14. Results Average costs of medications excluding the cost of PCA pump

  15. Conclusion • Intrathecal morphine provides adequate pain relief and is cost effective when considering all additional medications required by the patient. A direct comparison of the mean medication cost reveals a statistically significant yet small savings; however, the amount saved by using Duramorph spinal is $336.32 per patient when considering all charges to the patient.

  16. References • Cunningham, Leveno, et al.  Willimas Obstetrics. 22nd ed.  New York: McGraw-Hill, 2005. 473-490, 588-590. • Gabbe, Niebyl, et al.,eds.  Obstetrics: Normal and Problem Pregnancies.  4th ed. Philadelphia: Churchill Livingston, 2002. 539-543, 458-465

  17. Thank You • Dr. Casanova • Dr. Prien • Karen Lemons • Shane Terrell • Todd Jackson, RPh.

More Related